RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.94B
AUM Growth
-$52.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$54.6M
2
+$28.8M
3
+$27.6M
4
JBIO
Jade Biosciences
JBIO
+$27.2M
5
TYRA icon
Tyra Biosciences
TYRA
+$14.8M

Top Sells

1
+$58.6M
2
+$46.8M
3
+$45.6M
4
URGN icon
UroGen Pharma
URGN
+$35.5M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$32M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
– –
-3,181,818
77
– –
-190,256
78
– –
-1,750,000
79
– –
-4,004,610
80
– –
-546,554
81
– –
-1,333,333
82
– –
-29,606
83
– –
-3,032,808
84
– –
-443,464
85
– –
-3,206,271
86
– –
-575,000
87
– –
-1,295,040
88
– –
-3,217,503
89
– –
-3,312,356
90
– –
-1,347,252
1 2 3
4